A Randomised, Double-Blind, Placebo Controlled, Parallel Group , Flexible Dose Study to Evaluate the Efficacy and Safety of Paxil Tablets in Children and Adolescents With Major Depressive Disorder Post-Marketing Clinical Study

Trial Profile

A Randomised, Double-Blind, Placebo Controlled, Parallel Group , Flexible Dose Study to Evaluate the Efficacy and Safety of Paxil Tablets in Children and Adolescents With Major Depressive Disorder Post-Marketing Clinical Study

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 05 Aug 2016

At a glance

  • Drugs Paroxetine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 10 Sep 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 13 May 2011 Actual end date Feb 2011 added as reported by ClinicalTrials.gov
    • 13 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top